Clinical analysis evaluates blood pressure changes in people with human immunodeficiency virus, highlighting risks of sustained hypertension from integrase inhibitors.
Integrase strand transfer inhibitors (INSTIs) are a commonly used antiretroviral therapy (ART) class in people with human immunodeficiency virus (HIV) and associated with weight gain. We studied the association of INSTI-based ART with systolic and diastolic blood pressure (SBP and DBP).
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: